Cargando…
Th17 Pathway As a Target for Multipotent Stromal Cell Therapy in Dogs: Implications for Translational Research
Detrimental Th17 driven inflammatory and autoimmune disease such as Crohn’s disease, graft versus host disease and multiple sclerosis remain a significant cause of morbidity and mortality worldwide. Multipotent stromal/stem cell (MSC) inhibit Th17 polarization and activation in vitro and in rodent m...
Autores principales: | Kol, A., Walker, N. J., Nordstrom, M., Borjesson, D. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752288/ https://www.ncbi.nlm.nih.gov/pubmed/26872054 http://dx.doi.org/10.1371/journal.pone.0148568 |
Ejemplares similares
-
Multipotent Stromal Cells and Viral Interaction: Current Implications for Therapy
por: Taechangam, Nopmanee, et al.
Publicado: (2021) -
Placenta-derived multipotent mesenchymal stromal cells: a promising potential cell-based therapy for canine inflammatory brain disease
por: Amorim, Rogério Martins, et al.
Publicado: (2020) -
Meniscus Regeneration With Multipotent Stromal Cell Therapies
por: Zhou, Yun-Feng, et al.
Publicado: (2022) -
Identification of a Candidate Proteomic Signature to Discriminate Multipotent and Non-Multipotent Stromal Cells
por: Rosu-Myles, Michael, et al.
Publicado: (2012) -
Cytoplasmic-targeted parvalbumin blocks the proliferation of multipotent mesenchymal stromal cells in prophase
por: Melo, Carolina Soares Barros, et al.
Publicado: (2013)